BioCrine
  • Home
  • About Us
    • Company and People
    • Board of Directors
    • Management
    • Partners
  • Research Programs
    • Pipeline overview
    • Diabetes as a disease
    • Biocrine drug discovery strategy
    • Serum factor apoCIII
    • Insulin receptor isoforms
    • Calcium channels
    • Inositol pyrophosphates
  • InSight Technology
    • What is it?
    • How does it work?
    • Where can it be used?
  • News
  • Contact
Home » News » Company news » Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours

Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours

Newly published article in Scientific Reports (www.nature.com/scientificreports) about the development of a novel platform for intravital 3D imaging of RT2 tumours to facilitate real-time studies of cancer progression.

Full access to article is found HERE.

November 28, 2019 Catharina Rahm

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

Recent posts

  • Professor Berggren’s research publications
    Professor Berggren’s research publications November 17, 2020
  • Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye
    Intraocular Pressure Monitoring Following Islet Transplantation to the Anterior Chamber of the Eye November 28, 2019
  • Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours
    Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours November 18, 2019
  • Novel findings explain indirect regulation of glucose homeostasis
    Novel findings explain indirect regulation of glucose homeostasis August 21, 2019
  • Transplanted cells reveal early signs of type 1 diabetes
    Transplanted cells reveal early signs of type 1 diabetes May 15, 2019
  • ERC grant for research on insulin-producing cells
    ERC grant for research on insulin-producing cells April 1, 2019
  • Short anti-rejection therapy protects transplants in diabetic animals
    Short anti-rejection therapy protects transplants in diabetic animals February 1, 2019
  • Per-Olof Berggren invald i the American Academy of Arts and Sciences
    Per-Olof Berggren invald i the American Academy of Arts and Sciences October 4, 2018
  • New potential target for treatment of diabetes
    New potential target for treatment of diabetes July 29, 2018
  • Per-Olof Berggren elected member of the Korean Academy of Science and Technology
    Per-Olof Berggren elected member of the Korean Academy of Science and Technology June 13, 2018

Biocrine AB

Box 3073

169 03 Solna, Sweden

Contact Us

info at biocrine.se

www.biocrine.com

Copyright © 2012 Biocrine AB. All Rights Reserved